Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Construction in Progress: 2010-2015

Historic Construction in Progress for China Pharma Holdings (CPHI) over the last 5 years, with Sep 2015 value amounting to $19,747.

  • China Pharma Holdings' Construction in Progress fell 99.84% to $19,747 in Q3 2015 from the same period last year, while for Sep 2015 it was $19,747, marking a year-over-year decrease of 99.84%. This contributed to the annual value of $5,848 for FY2014, which is 99.98% down from last year.
  • Latest data reveals that China Pharma Holdings reported Construction in Progress of $19,747 as of Q3 2015, which was up 234.92% from $5,896 recorded in Q2 2015.
  • In the past 5 years, China Pharma Holdings' Construction in Progress ranged from a high of $29.7 million in Q2 2014 and a low of $5,848 during Q4 2014.
  • Its 3-year average for Construction in Progress is $11.5 million, with a median of $10.3 million in 2013.
  • Its Construction in Progress has fluctuated over the past 5 years, first skyrocketed by 4,227.86% in 2013, then crashed by 99.98% in 2015.
  • China Pharma Holdings' Construction in Progress (Quarterly) stood at $351,571 in 2011, then skyrocketed by 949.17% to $3.7 million in 2012, then soared by 591.26% to $25.5 million in 2013, then crashed by 99.98% to $5,848 in 2014, then crashed by 99.84% to $19,747 in 2015.
  • Its Construction in Progress was $19,747 in Q3 2015, compared to $5,896 in Q2 2015 and $5,876 in Q1 2015.